// changes done below on July 01 2024 // till here on July 01 2024

Large Volume Wearable Injectors: From Conception to Reality

Published: September 2014

Roots Analysis has announced the addition of Wearable Injectors Market report to its portfolio. The report is the second edition of the original publication titled “Bolus Injectors, 2014-2024” released in 2013. The focus of the latest edition is to provide a comprehensive analysis of the current state of the market, including detailed sales forecasts of these devices over the next ten years. Also known as bolus injectors and non-insulin patch pumps; these injectors not only offer a range of benefits to the end users but also provide a number of additional benefits to other stakeholders in the industry.

The absence of devices which can safely allow patients to self-administer large volume / highly viscous drugs is currently a big unmet need in the market. Despite the uncertainties related to the device development and approval, many established firms such as Becton Dickinson, West Pharmaceuticals and emerging players such as Unilife, SteadyMed Therapeutics, Ratio Drug Delivery, Sensile Medical, Enable Injections and scPharmaceuticals are heavily investing their time, money and resources to develop novel devices.

Rupali Verma, the principal analyst, said, “Our latest research has allowed us to further distil the list of over 250 drug-disease combinations that we had in the last year’s edition. You may remember that the starting point for us was over 900 biologics, most of which are currently in the pipeline. In the revised edition, we have lowered the ~250 drug-disease combinations to ~180. These 180 drug-disease combinations have been further categorized based upon their likely potential for delivery via bolus injectors in the future.”

Amongst other things, the report also includes detailed case studies on specific drugs such as Herceptin, AMG-145, Furosemide, Cephalosporin and ND0612L currently being targeted for delivery via large volume wearable injectors. The report extensively examines the insights gathered from interviews of important stakeholders such as West Pharmaceutical Services, Ratio Drug Delivery, Enable Injections and scPharmaceuticals.

Verma further stated, “One of the primary objectives of this report was to estimate size of the future promise offered by these injectors, which are currently available only for investigational use. By 2025, we expect more than 300 million units to be sold annually.”

In addition to the market forecasts over the next ten years (both in terms of volume and value), the report clearly identifies the various challenges and opportunities in the short and long term.

Who should buy this report?

This research is targeted towards big / small pharma companies which are working in the field of drug delivery and development. As biologics continue to grab an increasing share of the drugs market, their ease of administration is likely to play a prominent role. In particular, you could benefit from this report if you are looking to

  • Develop a comprehensive knowledge of the various bolus injector devices (usage mechanism, advantages, status of development)
  • Understand the competition and opportunities shaping this industry
  • Identify various drug-disease combinations that are likely to be a target for delivery via bolus injectors
  • Ascertain the likely volume of these devices and corresponding market size over the next ten years
  • Establish the right partnerships to either grow or enter this sector

You Can Download Free Sample PDF Copy of This Report At:

For additional details, please email at sales@rootsanalysis.com

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.


  • We are your partners with no equity

  • We fit in your budget

  • We love what we do

  • Chance to prove ourselves

  • Best in class quality of work

  • Most trusted consulting partner in the industry